Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,772,900
+$885,771 QoQ
Shares Held
65,000
+66.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#158
of 712 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $84,469,411 across 15 Drug Manufacturers - General names. SNY ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
159,049 | $40,393,674 | |
| 2 | MRK |
Merck & Co., Inc.
|
53,638 | $6,892,483 | |
| 3 | OGN |
Organon & Co.
|
497,996 | $6,742,865 | |
| 4 | BIIB |
Biogen Inc.
|
30,914 | $6,679,278 | |
| 5 | LLY |
ELI LILLY & Co
|
3,365 | $4,036,082 | |
| 6 | GRFS |
Grifols SA
|
550,746 | $3,899,281 | |
| 7 | ABBV |
AbbVie Inc.
|
14,719 | $3,703,889 | |
| 8 | SNY |
Sanofi
This page
|
65,000 | $2,772,900 |
All Filings in SNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,772,900 | 65,000 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $1,887,129 | 38,942 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $269,323 | 5,706 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,625,310 | 29,306 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $592,574 | 12,213 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||